NCT06850337View on ClinicalTrials.gov

Megakaryocyte Heterogeneity in Sickle Cell Disease

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Sickle Cell Disease (SCD)
Trial Locations (1)

97159

Chu de La Guadeloupe, Pointe-à-Pitre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Guadeloupe

OTHER

NCT06850337 - Megakaryocyte Heterogeneity in Sickle Cell Disease | Biotech Hunter | Biotech Hunter